Stem Cell Surgery Trials in Heart Failure and Diabetes: A Concise Guide

ISBN-13: 9783030780098 / Angielski / Miękka / 2022

Jeffrey N. Weiss

Spis treści

Table of Contents

PART I

U.S. Studies

Bone Marrow Derived Mesenchymal Stem Cells in Improving Heart Function in Patients With Heart Failure Caused by Anthracyclines

• MD Anderson Cancer Center

Houston, Texas

Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

• MD Anderson Cancer Center

Houston, Texas

The Transendocardial Autologous Cells (hMSC) or (hMSC) and (hCSC) in Ischemic Heart Failure Trial.

• ISCI / University of Miami

Miami, Florida

Regression of Fibrosis & Reversal of Diastolic Dysfunction in HFPEF Patients Treated With Allogeneic CDCs

• Medical University of South Carolina

Charleston, South Carolina

Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells(Rexlemestrocel-L) for the Treatment of Heart Failure.

• Mesoblast Investigational Site 10757 - Cardiology, P.C.

Birmingham, Alabama

• Mesoblast Investigational Site 13262 - University of Alabama at Birmingham Hospital

Birmingham, Alabama

• Mesoblast Investigational Site 10779 - Mercy Gilbert Medical Center

Gilbert, Arizona

• (and 56 more...)

Europe

Allogeneic Stem Cell Therapy in Heart Failure

• Cardiac Catheterization Laboratory 2014, The Heart Centre, University Hospital, Rigshospitalet

Copenhagen Ø, Denmark

• Cardiac Catheterization Laboratory 2014, The Heart Centre, University Hospital, Rigshospitalet

Copenhagen Ø, Denmark

Stem Cells Therapy in Advanced Heart Failure

• Celestino Sardu

Naples, Italy

• Raffaele Marfella

Naples, Italy

• Celestino Sardu

Napoli, Italy

Stem Cell Therapy in Ischemic Non-treatable Cardiac Disease

• 2014 Department of Cardiology, The Heart Centre, University Hospital Rigshospitalet

Copenhagen, Denmark

Infusion Intracoronary of Mononuclear Autologous Adult no Expanded Stem Cells of Bone Marrow on Functional Recovery in Patients With Idiopathic Dilated Cardiomyopathy and Heart Failure.

• Hospital Universitario Puerta del Mar

Cádiz, Spain

• Hopistal Universitario Reina Sofía

Córdoba, Spain

• Hospital Universitario Virgen de las Nieves

Granada, Spain

• (and 6 more...)

Cell Therapy in HFpEF

• University Medical Center Ljubljana

Ljubljana, Slovenia

Compare the Effects of Single Versus Repeated Intracoronary Application of Autologous Bone Marrow-derived Mononuclear Cells on Mortality in Patients With Chronic Post-infarction Heart Failure

• Zentralklinik Bad Berka

Bad Berka, Germany

• Goethe University Frankfurt

Frankfurt, Germany

• Klinikum Fulda

Fulda, Germany

• (and 3 more...)

Impact of Intracoronary Injection of Autologous BMMC for LV Contractility and Remodeling in Patients With STEMI

• Polsko-Amerykańskie Kliniki Serca

Ustroń, Poland

Stem Cell Therapy in Non-Ischemic Non-treatable Dilated Cardiomyopathies II: a Pilot Study

• The Heart Centre, Rigshospitalet University Hospital Copenhagen,

Copenhagen, Denmark

Iran

IMMNC-HF: IntraMyocardial Injection of Bone Marrow MonoNuclear Cells in Heart Failure (HF) Patients

• Stem Cell and Regenerative Medicine Institute (SCARM)

Tabriz, Islamic Republic of Iran

ICMNC-HF. IntraCoronary Bone Marrow MonoNuclear Cells in Heart Failure (HF) Patients

• Stem Cell and Regenerative Medicine Institute (SCARM)

Tabriz, Islamic Republic of Iran

China

Treating Heart Failure With hPSC-CMs

• HelpThera

Nanjing, Jiangsu, China

PART II

Type 1 Diabetes 

US Studies

China

China/Spain

South America

Canada

Middle East

Sweden

Type 2 Diabetes 

US Studies

China

Near East

Vietnam

Other Thoughts

O autorze

Jeffrey N. Weiss, M.D. 

The Healing Institute

Margate, FL

USA

Jeffrey N. Weiss, MD is the former Chief of Retinal Surgery at the Joslin Diabetes Center in Boston, Faculty of Harvard Medical School, and Visiting Scientist at the Massachusetts Institute of Technology. He entered college at 16 years of age, and medical school at age 19 on full scholarships. While in medical school he obtained a degree in Electrical Engineering, Magna Cum Laude with distinction, and graduated from Medical School, Summa Cum Laude, at 23 years of age.

Dr. Weiss is the author of more than 100 publications, including 11 books, holds more than 20 U.S. and foreign patents, and has been a Reviewer for multiple scholarly journals. He has served as a Visiting Professor, performed surgery, and lectured nationally and internationally. Dr. Weiss is also the founder of two companies, Ocular Research Associates Inc., and Micron Ophthalmic, Inc. which have manufactured and sold Dr. Weiss’ inventions worldwide.

Dr. Weiss performed the first retinal stem cell surgery in the world in 2010 and is the Principal Investigator of The Stem Cell Ophthalmology Treatment Studies I/II, the largest retinal and optic nerve stem cell studies in the world, The Neurologic Stem Cell Treatment Study, The Stem Cell Spinal Cord Injury Exoskeleton and Virtual Reality Treatment Study, and The Alzheimer’s, Cognitive Impairment and Autism Treatment Study. The studies are Institutional Review Board (IRB) approved, registered with NIH and listed on ClinicalTrials.gov.

Dr. Weiss first visited Dubai in 2008, where equipment he had invented was being showcased at Arab Health, the second largest medical equipment meeting in the world. In 2015, he obtained a Dubai medical license and has been travelling to Dubai to examine patients, perform surgery and lecture. His work has been featured in all the major Dubai newspapers and television. He was a finalist for the United Arab Emirates HealthCare Award in 2018 and 2019.

Blurb

This book examines the application of stem cell surgery for diabetes and heart failure.

Organized into two sections, the first identifies and summarizes the current worldwide stem cell trials for heart failure. Subsequent chapters in part two analyze the current worldwide stem cell trials in patients with Diabetes Mellitus. Both sections utilize studies that include non-expanded stem cells; each study is grouped by stem cell type and geographic location.

Stem Cell Surgery Trials in Diabetes and Heart Failure is a comprehensive, convenient reference for cardiologists, endocrinologists, internists, and family physicians.